|
US3598122A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US4144317A
(en)
|
1975-05-30 |
1979-03-13 |
Alza Corporation |
Device consisting of copolymer having acetoxy groups for delivering drugs
|
|
US4262003A
(en)
|
1975-12-08 |
1981-04-14 |
Alza Corporation |
Method and therapeutic system for administering scopolamine transdermally
|
|
US4201211A
(en)
|
1977-07-12 |
1980-05-06 |
Alza Corporation |
Therapeutic system for administering clonidine transdermally
|
|
US4525586A
(en)
|
1980-02-28 |
1985-06-25 |
The Upjohn Company |
Composition and process
|
|
US4338457A
(en)
|
1980-02-28 |
1982-07-06 |
The Upjohn Company |
Composition and process
|
|
US4306075A
(en)
|
1980-03-28 |
1981-12-15 |
The Upjohn Company |
Composition and process
|
|
US4420632A
(en)
|
1980-04-15 |
1983-12-13 |
The Upjohn Company |
Composition and process
|
|
US4306076A
(en)
|
1980-04-23 |
1981-12-15 |
The Upjohn Company |
Inter-phenylene CBA compounds
|
|
US4349689A
(en)
|
1980-12-22 |
1982-09-14 |
The Upjohn Company |
Methano carbacyclin analogs
|
|
US4379454A
(en)
|
1981-02-17 |
1983-04-12 |
Alza Corporation |
Dosage for coadministering drug and percutaneous absorption enhancer
|
|
DE3333240A1
(de)
|
1983-09-12 |
1985-03-28 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Mittel zur transdermalen applikation von arzneimittelwirkstoffen
|
|
US4668814A
(en)
|
1984-03-08 |
1987-05-26 |
The Upjohn Company |
Interphenylene carbacyclin derivatives
|
|
US4683330A
(en)
|
1984-03-08 |
1987-07-28 |
The Upjohn Company |
Interphenylene carbacyclin derivatives
|
|
GB8824187D0
(en)
|
1988-10-14 |
1988-11-23 |
Wellcome Found |
Compounds for use in medicine
|
|
GB8814438D0
(en)
|
1988-06-17 |
1988-07-20 |
Wellcome Found |
Compounds for use in medicine
|
|
US5088977A
(en)
|
1988-12-21 |
1992-02-18 |
Drug Delivery Systems Inc. |
Electrical transdermal drug applicator with counteractor and method of drug delivery
|
|
CA2056039A1
(en)
|
1991-01-22 |
1992-07-23 |
Philip L. Fuchs |
Carbacyclin analogs
|
|
US5234690A
(en)
|
1991-08-23 |
1993-08-10 |
Cygnus Therapeutic Systems |
Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
|
|
US5869505A
(en)
|
1993-02-02 |
1999-02-09 |
Keenan; Robert M. |
Nicotine metabolites and nicotine dependence
|
|
US5853751A
(en)
|
1993-06-23 |
1998-12-29 |
Masiz; John J. |
Molecular transdermal transport system
|
|
US5797898A
(en)
|
1996-07-02 |
1998-08-25 |
Massachusetts Institute Of Technology |
Microchip drug delivery devices
|
|
IN184589B
(enExample)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
|
EP1164846A1
(en)
*
|
1999-03-31 |
2002-01-02 |
United Therapeutics Corporation |
Prostaglandin compounds, compositions and methods of treating peripheral vascular disease and pulmonary hypertension
|
|
AU3104301A
(en)
|
2000-01-20 |
2001-07-31 |
Noven Pharmaceuticals, Inc. |
Compositions and methods to effect the release profile in the transdermal administration of active agents
|
|
US6242482B1
(en)
|
2000-06-05 |
2001-06-05 |
United Therapeutics Corporation |
Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure
|
|
US6635274B1
(en)
|
2000-10-27 |
2003-10-21 |
Biochemics, Inc. |
Solution-based transdermal drug delivery system
|
|
US6700025B2
(en)
|
2001-01-05 |
2004-03-02 |
United Therapeutics Corporation |
Process for stereoselective synthesis of prostacyclin derivatives
|
|
US20030108512A1
(en)
|
2001-12-10 |
2003-06-12 |
Robert Shorr |
Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer
|
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
|
ES2670872T3
(es)
*
|
2003-05-22 |
2018-06-01 |
United Therapeutics Corporation |
Polimorfo de una sal de dietanolamina de treprostinil
|
|
CA2530407A1
(en)
*
|
2003-07-23 |
2005-02-03 |
The Regents Of The University Of California |
Penetration enhancer combinations for transdermal delivery
|
|
US7375139B2
(en)
|
2003-08-18 |
2008-05-20 |
Aldred Katherine M |
Transdermal method and apparatus
|
|
JP2005120069A
(ja)
|
2003-10-13 |
2005-05-12 |
Anges Mg Inc |
炎症性疾患治療薬
|
|
JP4906514B2
(ja)
|
2003-12-16 |
2012-03-28 |
ユナイテッド セラピューティクス コーポレイション |
腎臓機能改善のためのトレプロスチニルの用途
|
|
US8765813B2
(en)
*
|
2003-12-16 |
2014-07-01 |
United Therapeutics Corporation |
Use of treprostinil to treat and prevent ischemic lesions
|
|
CA2562614C
(en)
|
2004-04-12 |
2013-09-17 |
United Therapeutics, Inc. |
Use of treprostinil to treat neuropathic diabetic foot ulcers
|
|
WO2006015299A2
(en)
|
2004-07-30 |
2006-02-09 |
Microchips, Inc. |
Multi-reservoir device for transdermal drug delivery and sensing
|
|
MX2007004315A
(es)
|
2004-10-08 |
2008-03-11 |
Noven Pharma |
Dispositivo para suministro transdermico de farmaco que incluye un respaldo oclusivo.
|
|
KR20130114229A
(ko)
|
2005-06-03 |
2013-10-16 |
애크럭스 디디에스 피티와이 리미티드 |
경피 약물 전달 방법 및 조성물
|
|
EA200801369A1
(ru)
|
2005-12-20 |
2009-02-27 |
ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. |
Способы трансдермального введения агониста рецептора индолсеротонина и трансдермальные лекарственные формы для применения этого способа
|
|
EP1988910B1
(en)
|
2006-02-28 |
2017-12-06 |
Kodiak Sciences Inc. |
Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
|
|
US8747897B2
(en)
|
2006-04-27 |
2014-06-10 |
Supernus Pharmaceuticals, Inc. |
Osmotic drug delivery system
|
|
JP5797376B2
(ja)
|
2006-05-15 |
2015-10-21 |
ユナイテッド セラピューティクス コーポレーション |
定量吸入器を用いたトレプロスチニル投与
|
|
WO2008002929A2
(en)
|
2006-06-26 |
2008-01-03 |
Inverseon, Inc. |
Heterologous cross-sensitization for improved agonist activity
|
|
US20090036465A1
(en)
|
2006-10-18 |
2009-02-05 |
United Therapeutics Corporation |
Combination therapy for pulmonary arterial hypertension
|
|
US20080280986A1
(en)
|
2007-02-09 |
2008-11-13 |
United Therapeutics Corporation |
Treprostinil treatment for interstitial lung disease and asthma
|
|
KR20100046189A
(ko)
|
2007-07-11 |
2010-05-06 |
렉시컨 파마슈티컬스 인코퍼레이티드 |
폐고혈압 및 관련 질환 및 장애의 치료를 위한 방법 및 조성물
|
|
WO2009078965A1
(en)
*
|
2007-12-17 |
2009-06-25 |
United Therapeutics Corporation |
An improved process to prepare treprostinil, the active ingredient in remodulin
|
|
WO2009152160A1
(en)
|
2008-06-10 |
2009-12-17 |
Gilead Sciences, Inc. |
Inhaled carbaprostacyclin and prostacyclin prodrugs for the treatment of pulmonary arterial hypertension
|
|
US20110294815A1
(en)
|
2008-06-27 |
2011-12-01 |
Harbeson Scott L |
Prostacyclin analogs
|
|
ES2763176T3
(es)
|
2008-08-13 |
2020-05-27 |
Actelion Pharmaceuticals Ltd |
Composiciones terapéuticas que contienen macitentan
|
|
JP5851246B2
(ja)
|
2008-12-30 |
2016-02-03 |
リグスホスピタルＲｉｇｓｈｏｓｐｉｔａｌｅｔ |
臓器不全の発生リスクが上昇した重篤患者を識別する方法およびその治療のための化合物
|
|
EP2427054A4
(en)
|
2009-05-07 |
2014-01-15 |
United Therapeutics Corp |
SOLID COMPOSITIONS BASED ON PROSTACYCLINE ANALOGS
|
|
US8519178B2
(en)
|
2009-06-22 |
2013-08-27 |
Johnson Matthey Public Limited Company |
Method for the purification of prostaglandins
|
|
US20120184622A1
(en)
|
2009-08-07 |
2012-07-19 |
Scipharm Sarl |
Composition for the treatment of cystic fibrosis
|
|
US9327105B2
(en)
*
|
2010-03-26 |
2016-05-03 |
Itrace Biomedical Inc. |
Active transdermal drug delivery system and the method thereof
|
|
US8557961B2
(en)
|
2010-04-02 |
2013-10-15 |
Amunix Operating Inc. |
Alpha 1-antitrypsin compositions and methods of making and using same
|
|
EP4450523A3
(en)
|
2010-04-02 |
2025-03-12 |
Amunix Pharmaceuticals, Inc. |
Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
|
|
US20130040898A1
(en)
|
2010-04-29 |
2013-02-14 |
Pär Johansson |
Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof
|
|
US8481782B2
(en)
|
2010-06-03 |
2013-07-09 |
United Therapeutics Corporation |
Treprostinil production
|
|
US20120010159A1
(en)
|
2010-07-09 |
2012-01-12 |
United Therapeutics Corporation |
Combination therapies with cox-2 inhibitors and treprostinil
|
|
CA2710726C
(en)
|
2010-07-22 |
2016-02-23 |
Alphora Research Inc. |
Synthesis of treprostinil and intermediates useful therein
|
|
CA2726599C
(en)
|
2010-12-30 |
2017-07-25 |
Alphora Research Inc. |
Process for treprostinil salt preparation
|
|
ES2693622T3
(es)
|
2011-01-13 |
2018-12-13 |
SciPharm S.à r.l. |
Método para mejorar el injerto de células madre hematopoyéticas
|
|
SI2672957T1
(sl)
|
2011-02-07 |
2017-03-31 |
Scipharm Sarl |
Nova sestava za zdravljenje cistične fibroze
|
|
WO2012107364A1
(en)
|
2011-02-07 |
2012-08-16 |
Scipharm Sàrl |
Novel composition for the treatment of cystic fibrosis
|
|
BR112013027009A2
(pt)
|
2011-04-19 |
2016-12-27 |
Rigshospitalet |
prostaciclina e análogos da mesa administrada durante cirurgia para prevenção e tratamento de derrame capilar
|
|
WO2013022846A2
(en)
|
2011-08-05 |
2013-02-14 |
Cardero Therapeutics, Inc. |
Flavonoid compounds
|
|
EP2741781A1
(en)
|
2011-08-12 |
2014-06-18 |
Ascendis Pharma A/S |
Carrier-linked treprostinil prodrugs
|
|
CA2843506C
(en)
|
2011-08-12 |
2020-05-12 |
Ascendis Pharma A/S |
Carrier-linked prodrugs having reversible carboxylic ester linkages
|
|
US9872864B2
(en)
|
2011-08-12 |
2018-01-23 |
Ascendis Pharma A/S |
Sustained release composition of prostacyclin
|
|
US8524939B2
(en)
|
2011-08-24 |
2013-09-03 |
Chirogate International Inc. |
Intermediates for the synthesis of benzindene prostaglandins and preparations thereof
|
|
CN103193627B
(zh)
*
|
2012-01-10 |
2016-04-20 |
上海天伟生物制药有限公司 |
一种前列腺素类似物的晶型及其制备方法和用途
|
|
US9387214B2
(en)
|
2012-01-13 |
2016-07-12 |
United Therapeutics Corporation |
Method of identifying therapies for pulmonary hypertension
|
|
WO2013143548A1
(en)
|
2012-03-30 |
2013-10-03 |
Rigshospitalet |
Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest
|
|
AU2013254756B2
(en)
|
2012-04-25 |
2017-03-30 |
Ascendis Pharma A/S |
Prodrugs of hydroxyl-comprising drugs
|
|
LT2674413T
(lt)
|
2012-06-15 |
2017-09-25 |
Scipharm Sąrl |
Treprostinilo ir jo darinių gavimo būdas
|
|
IN2015DN00934A
(enExample)
|
2012-08-01 |
2015-06-12 |
United Therapeutics Corp |
|
|
MX369094B
(es)
|
2012-12-07 |
2019-10-29 |
Cayman Chemical Co Inc |
Metodos para sintetizar un analogo de prostaciclina.
|
|
AU2014205557B2
(en)
|
2013-01-09 |
2017-08-10 |
United Therapeutics Corporation |
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
|
|
US9505737B2
(en)
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
|
ES2927844T3
(es)
|
2013-01-11 |
2022-11-11 |
Corsair Pharma Inc |
Profármacos de treprostinil
|
|
KR20150128903A
(ko)
|
2013-03-15 |
2015-11-18 |
유나이티드 세러퓨틱스 코오포레이션 |
트레프로스티닐의 염
|
|
WO2014160638A1
(en)
|
2013-03-25 |
2014-10-02 |
United Therapeutics Corporation |
Process of making prostacyclin compounds with linker thiol and pegylated forms
|
|
EP2991639A4
(en)
|
2013-04-30 |
2016-11-30 |
United Therapeutics Corp |
PHARMACEUTICAL FORMULATIONS WITH CONTROLLED RELEASE
|
|
WO2014203278A2
(en)
|
2013-06-19 |
2014-12-24 |
Msn Laboratories Private Limited |
NOVEL PROCESS FOR THE PREPARATION OF (1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-HEXAHYDRO-2-HYDROXY-1-[(3S)-3-HYDROXYOCTYL]-1H-BENZ[f]INDEN-5-YL]OXY]ACETIC ACID
|
|
SI3060041T1
(sl)
|
2013-10-25 |
2021-04-30 |
Insmed Incorporated |
Spojine prostaciklina
|
|
US9890104B2
(en)
|
2013-11-13 |
2018-02-13 |
Cayman Chemical Company Incorporated |
Amine salts of a prostacyclin analog
|
|
WO2015138423A1
(en)
|
2014-03-11 |
2015-09-17 |
Insmed Incorporated |
Prostacylin compositions and methods for using the same
|
|
JP6561109B2
(ja)
|
2014-07-16 |
2019-08-14 |
コルセア ファーマ インコーポレイテッド |
トレプロスチニル誘導体化合物およびその使用方法
|
|
HU231184B1
(hu)
|
2014-10-08 |
2021-07-28 |
CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. |
Treprostinil-nátrium-monohidrát és eljárás ennek előállítására
|
|
EP3904326A1
(en)
|
2014-11-18 |
2021-11-03 |
Insmed Incorporated |
Methods of manufacturing treprostinil and treprostinil derivative prodrugs
|
|
TWI540121B
(zh)
|
2014-12-01 |
2016-07-01 |
臺灣永光化學工業股份有限公司 |
曲前列環素二乙醇胺之合成方法及新穎中間體
|
|
EA201791696A1
(ru)
|
2015-01-27 |
2017-11-30 |
Сифарм Сарл |
Композиция для лечения веноокклюзионной болезни печени
|
|
US20160243064A1
(en)
|
2015-02-21 |
2016-08-25 |
Gavis Pharmaceuticals |
Novel oral pharmaceutical compositions of treprostinil
|
|
WO2016176555A1
(en)
|
2015-04-29 |
2016-11-03 |
Insmed Incorporated |
Prostacyclin compounds, compositions and methods of use thereof
|
|
US9394227B1
(en)
|
2015-06-17 |
2016-07-19 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
|
US9643911B2
(en)
*
|
2015-06-17 |
2017-05-09 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
|
EP3548010A1
(en)
|
2016-12-05 |
2019-10-09 |
Corsair Pharma, Inc. |
Dermal and transdermal administration of treprostinil and salts thereof
|